On Friday, Nuvalent Inc (NUVL) stock saw a modest uptick, ending the day at $89.22 which represents a slight increase of $0.73 or 0.82% from the prior close of $88.49. The stock opened at $89 and ...

UBS Group began coverage on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $100. ...

Porter James Richard, the President and CEO of Nuvalent, Inc. (NASDAQ:NUVL), recently executed a series of stock transactions according to a Form 4 filing with the Securities and Exchange Commission.

UBS initiated coverage of Nuvalent (NUVL) with a Neutral rating and $100 price target The firm launched coverage of SMID cap biotech sector with a focus in oncology and autoimmune diseases.

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Wednesday, shares of Nuvalent Inc (Symbol: NUVL) entered into oversold territory, hitting an RSI reading of 29 ...

Try Now>> See the top stocks recommended by analysts >> Read More on NUVL: Nuvalent NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Fintel reports that on October 24, 2024, UBS initiated coverage of Nuvalent (NasdaqGS:NUVL) with a Neutral recommendation.

Nuvalent, Inc. has a 52-week low of $49.02 and a 52-week high of $113.51. The firm has a market cap of $6.69 billion, a price-to-earnings ratio of -43.02 and a beta of 1.29. Get Nuvalent alerts ...

As of October 22, 2024, the average one-year price target for Nuvalent is $115.82/share. The forecasts range from a low of $97.97 to a high of $141.75. The average price target represents an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the ...